Here we have investigated the effects of Acrp30 and ERα in the absence of other factors such as oestradiol, leptin or serum on a number of breast cancer cell lines to clarify the role of Acrp30 on cell growth and how ERα without significant doses of high-affinity ligands may affect this role. Here, ADIPOQ is linked to breast carcinoma.